IBDEI0OT ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11074,0)
 ;;=H50.89^^77^722^26
 ;;^UTILITY(U,$J,358.3,11074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11074,1,3,0)
 ;;=3^Strabismus NEC
 ;;^UTILITY(U,$J,358.3,11074,1,4,0)
 ;;=4^H50.89
 ;;^UTILITY(U,$J,358.3,11074,2)
 ;;=^88142
 ;;^UTILITY(U,$J,358.3,11075,0)
 ;;=H55.00^^77^722^29
 ;;^UTILITY(U,$J,358.3,11075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11075,1,3,0)
 ;;=3^Nystagmus,Unspec
 ;;^UTILITY(U,$J,358.3,11075,1,4,0)
 ;;=4^H55.00
 ;;^UTILITY(U,$J,358.3,11075,2)
 ;;=^5006370
 ;;^UTILITY(U,$J,358.3,11076,0)
 ;;=I67.9^^77^722^38
 ;;^UTILITY(U,$J,358.3,11076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11076,1,3,0)
 ;;=3^Cerebrovascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,11076,1,4,0)
 ;;=4^I67.9
 ;;^UTILITY(U,$J,358.3,11076,2)
 ;;=^5007389
 ;;^UTILITY(U,$J,358.3,11077,0)
 ;;=M31.6^^77^722^1
 ;;^UTILITY(U,$J,358.3,11077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11077,1,3,0)
 ;;=3^Giant Cell Arteritis NEC
 ;;^UTILITY(U,$J,358.3,11077,1,4,0)
 ;;=4^M31.6
 ;;^UTILITY(U,$J,358.3,11077,2)
 ;;=^5011748
 ;;^UTILITY(U,$J,358.3,11078,0)
 ;;=R25.0^^77^722^37
 ;;^UTILITY(U,$J,358.3,11078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11078,1,3,0)
 ;;=3^Abnormal Head Movements
 ;;^UTILITY(U,$J,358.3,11078,1,4,0)
 ;;=4^R25.0
 ;;^UTILITY(U,$J,358.3,11078,2)
 ;;=^5019299
 ;;^UTILITY(U,$J,358.3,11079,0)
 ;;=R51.^^77^722^30
 ;;^UTILITY(U,$J,358.3,11079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11079,1,3,0)
 ;;=3^Headache
 ;;^UTILITY(U,$J,358.3,11079,1,4,0)
 ;;=4^R51.
 ;;^UTILITY(U,$J,358.3,11079,2)
 ;;=^5019513
 ;;^UTILITY(U,$J,358.3,11080,0)
 ;;=H51.9^^77^722^39
 ;;^UTILITY(U,$J,358.3,11080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11080,1,3,0)
 ;;=3^Binocular Movement Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,11080,1,4,0)
 ;;=4^H51.9
 ;;^UTILITY(U,$J,358.3,11080,2)
 ;;=^5006258
 ;;^UTILITY(U,$J,358.3,11081,0)
 ;;=D86.82^^77^722^40
 ;;^UTILITY(U,$J,358.3,11081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11081,1,3,0)
 ;;=3^Multiple Cranial Nerve Palsies in Sarcoidosis
 ;;^UTILITY(U,$J,358.3,11081,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,11081,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,11082,0)
 ;;=H51.11^^77^722^21
 ;;^UTILITY(U,$J,358.3,11082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11082,1,3,0)
 ;;=3^Convergence Insufficiency
 ;;^UTILITY(U,$J,358.3,11082,1,4,0)
 ;;=4^H51.11
 ;;^UTILITY(U,$J,358.3,11082,2)
 ;;=^5006251
 ;;^UTILITY(U,$J,358.3,11083,0)
 ;;=H50.51^^77^722^22
 ;;^UTILITY(U,$J,358.3,11083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11083,1,3,0)
 ;;=3^Esophoria
 ;;^UTILITY(U,$J,358.3,11083,1,4,0)
 ;;=4^H50.51
 ;;^UTILITY(U,$J,358.3,11083,2)
 ;;=^265435
 ;;^UTILITY(U,$J,358.3,11084,0)
 ;;=H50.00^^77^722^23
 ;;^UTILITY(U,$J,358.3,11084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11084,1,3,0)
 ;;=3^Esotropia,Unspec
 ;;^UTILITY(U,$J,358.3,11084,1,4,0)
 ;;=4^H50.00
 ;;^UTILITY(U,$J,358.3,11084,2)
 ;;=^5006208
 ;;^UTILITY(U,$J,358.3,11085,0)
 ;;=H50.52^^77^722^24
 ;;^UTILITY(U,$J,358.3,11085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11085,1,3,0)
 ;;=3^Exophoria
 ;;^UTILITY(U,$J,358.3,11085,1,4,0)
 ;;=4^H50.52
 ;;^UTILITY(U,$J,358.3,11085,2)
 ;;=^265436
 ;;^UTILITY(U,$J,358.3,11086,0)
 ;;=H50.10^^77^722^25
 ;;^UTILITY(U,$J,358.3,11086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11086,1,3,0)
 ;;=3^Exotropia,Unspec
 ;;^UTILITY(U,$J,358.3,11086,1,4,0)
 ;;=4^H50.10
